Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Caitlin E. Cox

May 19, 2025

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

News Daily News

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

Caitlin E. Cox

July 23, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Daily News

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

Caitlin E. Cox

July 13, 2023

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

Caitlin E. Cox

April 05, 2021

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News EuroPCR 2020

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

L.A. McKeown

July 01, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

Advertisement

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

TAVR Operators: Can One Do It All or Are Two Still Justified?

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content